Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development.

Mol Ther Oncolytics · 2021 · PMC8411212 · PMID 34514091

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In the MC38 tumor-bearing C57BL/6 syngeneic model ( Figure 5 A), vvDD- and ΔA46R-treated mice showed a trend toward improved survival over mock-treated mice.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.